Floatz logo

MERCAPTOPURINE ANHYDROUS

Acute Myelogenous Leukemia

University Hospital, AntwerpSmall moleculePhase 3Active
BB
68/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
61/ 100
Competitive Position
81/ 100

Competitive context

25 Active assets in the Acute Myelogenous Leukemia cohort.

Asset / SponsorPhaseRating
Posaconazole
AstraZeneca
Phase 4BBB
Vesanoid
The First Affiliated Hospital of Soochow University
Phase 3BB
Allogeneic Cd34+-Enriched And Cd45Ra-Depleted Pbscs
Fred Hutchinson Cancer Center
Phase 2/3BB
Valproic Acid
University of Bergen
Phase 2BB
Plerixafor
Washington University School of Medicine
Phase 2BB

View all 50 →

Same molecule, other indications

MERCAPTOPURINE ANHYDROUS is also rated in:

adult acute lymphoblastic leukemiaDormant
A
Indicative ·
81 / 100
View asset →
B-cell childhood acute lymphoblastic leukemiaDormant
A
Indicative ·
80 / 100
View asset →
childhood acute lymphoblastic leukemiaDormant
BBB
Indicative ·
75 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →